Temc CNS
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Temc CNS makes specialty chemicals and equipment used in semiconductor manufacturing, specifically the chemical materials that help build the ultra-thin layers inside chips, and the automated systems that deliver those chemicals to production lines.
It supplies chipmakers at the front-end and back-end stages of semiconductor fabrication, and also produces equipment for secondary-battery (rechargeable-cell) factories. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates across two distinct product lines: chemical precursors and specialty gases used in deposition and etching processes, and centralized chemical-supply systems that mix and dispense those materials on the factory floor.
Summary is AI-generated and may contain errors · figures from DART filings
Temc CNS in five facts
What does Temc CNS do?
Temc CNS makes specialty chemicals and equipment used in semiconductor manufacturing, specifically the chemical materials that help build the ultra-thin layers inside chips, and the automated systems that deliver those chemicals to production lines.
Where is Temc CNS listed and in which sector?
Temc CNS (Korean name: 티이엠씨씨엔에스) trades under KRX code 241790 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Machinery.
How large is Temc CNS?
Its market capitalisation was US$48.9M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Temc CNS's latest annual revenue and operating profit?
For fiscal year 2025, Temc CNS reported revenue of US$126.8M, operating profit of US$6.8M and net income of US$3.2M, per its annual report on DART (data retrieved from DART on 2026-09-18). Revenue was down 13.2% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-09-18
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- Material event report (treasury share trust agreement)Aug 31
- Supply contract signed
Temc CNS disclosed a supply contract with SK Hynix, worth US$16.3M, about 15.03% of its recent annual revenue, running through Nov 2026.
Supply contract · Jun 26 - Cash/in-kind dividend decision
Temc CNS declared a cash dividend of US$0.05 per share, equal to about 1% of the recent share price.
Dividend · Mar 9 - Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Temc CNS reported consolidated results for FY2025: revenue of US$115M (−13% year on year), operating profit of US$6.35M (+56.7% year on year) and net income of US$2.74M (−54.2% year on year).
Earnings · Feb 9